Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.330
-0.010 (-0.75%)
At close: Aug 1, 2025, 4:00 PM
1.330
0.00 (0.00%)
After-hours: Aug 1, 2025, 4:10 PM EDT

Vivani Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
8.778.93105.372.322.38
Research & Development
16.2415.7516.9714.17116.87
Operating Expenses
25.0124.6826.9719.5413.329.24
Operating Income
-25.01-24.68-26.97-19.54-13.32-9.24
Other Non Operating Income (Expenses)
1.261.191.310.480.55-0.04
EBT Excluding Unusual Items
-23.75-23.49-25.65-19.07-12.77-9.28
Legal Settlements
----1.7--
Other Unusual Items
---6.88--
Pretax Income
-23.75-23.49-25.65-13.89-12.77-9.28
Net Income
-23.75-23.49-25.65-13.89-12.77-9.28
Net Income to Common
-23.75-23.49-25.65-13.89-12.77-9.28
Shares Outstanding (Basic)
575551383310
Shares Outstanding (Diluted)
575551383310
Shares Change (YoY)
10.79%8.12%32.98%15.56%234.38%-
EPS (Basic)
-0.42-0.43-0.50-0.36-0.39-0.94
EPS (Diluted)
-0.42-0.43-0.50-0.36-0.39-0.94
Free Cash Flow
-21.82-21.34-24.59-19.13-11.52-7.77
Free Cash Flow Per Share
-0.38-0.39-0.48-0.50-0.35-0.79
EBITDA
-24.6-24.28-26.61-19.16-12.98-8.89
D&A For EBITDA
0.40.40.360.380.350.35
EBIT
-25.01-24.68-26.97-19.54-13.32-9.24
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q